FDA Flips It and Reverses It: FDA Withdraws HHS Withdrawal of UDI Guidance
FDA Law Blog
JUNE 9, 2021
Koblitz — While typically, FDA is responsible for setting forth its own agenda and enforcing compliance with its own regulations, the Trump Administration’s HHS, on its way out the door in late 2020 , took the unusual steps of withdrawing an important FDA Compliance Policy Guide, “Marketed Unapproved Drugs – Compliance Policy Guide Sec.
52 
Let's personalize your content